Brazil approves Pfizer COVID-19 vaccine for children over 12

World44 minutes ago (Jun 11, 2021 08:21AM ET)

2/2
(C) Reuters. FILE PHOTO: Rio de Janeiro’s Health secretary Daniel Soranz applies the first dose of Pfizer/BioNTech coronavirus disease (COVID-19) vaccine to citizen Alexandre Almeida to mark the beginning of its administration in Rio de Janeiro, Brazil May 4, 2021. RE

2/2

SAO PAULO (Reuters) -Brazil health regulator Anvisa on Friday said it had approved use of the Pfizer/BioNtech COVID-19 vaccine for children over 12 years of age.

Anvisa said it approved the measure after seeing studies, conducted outside Brazil, that showed safety and efficacy for the age group.

The vaccine, the first in Brazil to receive definitive approval from Anvisa, was already authorized for use on adolescents aged 16 and over, the regulator said. It added that the Pfizer (NYSE:PFE) vaccine was currently the only one authorized to be used on minors.

Brazil approves Pfizer COVID-19 vaccine for children over 12

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Stories

Discover

Popular Categories